Effect of Saliva Substitutes on Dental Hard Tissues in Situ
NCT ID: NCT01165970
Last Updated: 2011-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
19 participants
INTERVENTIONAL
2009-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Human saliva possesses important physiological functions in protecting and moistening the oral hard and soft tissues (Piotrowski et al., 1992, ). Consequently, decreasing salivation causes oral dysfunction and promotes severe oral side effects (reduced antibacterial function, lack of remineralisation, reduced buffer capacity) (Tschoppe et al., 2010a). These have been identified as being responsible for the rapid destruction of the dentition (Willich et al., 1988). Saliva substitutes are frequently applied for relieving the symptoms in patients suffering from hyposalivation (Hahnel et al., 2009, Nieuw Amerongen \& Veerman, 2003, Vissink et al., 2004). Besides the moistening and lubrication of the oral mucosa, these products should also protect dental hard tissues. However, in vitro studies revealed that some marketed products have only a neutral or even a demineralising potential on enamel as well as on dentin (Kielbassa et al., 2001, Meyer-Lueckel et al., 2002, Smith et al., 2001, Tschoppe et al., 2009). Inorganic ions such as calcium, phosphates, and fluorides have been added to saliva substitutes in order to enhance their remineralising property or minimize their demineralising potential (Tschoppe et al., 2009). Furthermore, as most patients suffering from hyposalivation are elderly people, recessions and subsequently exposed dentin surfaces are very common. Since dentin is not as acid resistant as enamel, an earlier and more severe demineralisation can be expected (Saunders \& Meyerowitz, 2005).
Therefore, the current in situ study was performed to assess the effects of a demineralising and a remineralising saliva substitutes on the mineralisation of dental hard tissues. It was hypothesized that storage in Glandosane(cell pharm, Hannover, Germany) would not result in pronounced mineral loss of dentin specimens, and that storage in Saliva natura would not result in enhanced remineralisation when combined with a remineralising artificial saliva (Saliva natura supersaturated with respect to relevant calcium phosphates; medac, Hamburg, Germany) (H0). These null hypotheses were tested against the alternative hypothesis of a difference.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glandosane
After in situ exposition the enamel and dentin samples will demineralize with Glandosane.
Glandosane
according to the german law the sued saliva substitute is a drug (Glandosane) whereas Saliva natura is a medical product
Saliva natura
After in situ exposition the enamel and dentin samples will remineralize with Saliva natura
Saliva natura
Saliva substitute without restriction to be used
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glandosane
according to the german law the sued saliva substitute is a drug (Glandosane) whereas Saliva natura is a medical product
Saliva natura
Saliva substitute without restriction to be used
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* partial denture upper or lower jaw
* radiationtherapy in the head and neck area
* patient age above 18 years
* Signed informed consent (AMG §40 (1) 3b)
Exclusion Criteria
* missing partial denture upper or lower jaw
* missing Radiationtherapy in the head and neck area
* paraben allergy
* not signed informed consent (AMG §40 (1) 3b)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Tschoppe
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Tschoppe, Dr
Role: PRINCIPAL_INVESTIGATOR
Department of Operative Dentistry and Periodontology, School of Dental Medicine, CharitéCentrum 3, Charité - Universitätsmedizin Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite, Berlin, Germany
Berlin, State of Berlin, Germany
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tschoppe P, Wolf O, Eichhorn M, Martus P, Kielbassa AM. Design of a randomized controlled double-blind crossover clinical trial to assess the effects of saliva substitutes on bovine enamel and dentin in situ. BMC Oral Health. 2011 Apr 9;11:13. doi: 10.1186/1472-6831-11-13.
Related Links
Access external resources that provide additional context or updates about the study.
please check the science subsite
Short review on the main problems in this patient population: Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int. 2010 Apr;41(4):321-33. Review.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-005451-23
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
T-01/2008-005451-23
Identifier Type: -
Identifier Source: org_study_id